Report cover image

Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022

Publisher GlobalData
Published Mar 07, 2022
SKU # GBDT17165911

Description

Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022

Summary

When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters.

The COVID-19 Clinical and Commercial Analyzer is an interactive Excel-based tool that scores leading pipeline-stage vaccines and therapeutics on a range of clinical and commercial parameters based on available clinical data. The catalyst for the initial release of this analysis, dated February 3, 2021, includes all clinical data readouts and other market-altering events that have occurred since the outbreak’s inception.

Key Highlights
  • Competitive Assessment: Visual representation of the results of the analyzer, depicting how the leading candidates compete.
  • Product Dashboard: Compilation of all key product features, plus a proprietary SWOT analysis of each product.
  • Clinical Data Summary: Listing of published clinical data for all products included in the analysis.
Scope



This analyzer includes -
  • Catalyst: Description of the most recent events impacting the COVID-19 R&D competitive landscape that are accounted for in the analysis
  • Scope of Coverage and Methodology: Discussion of product inclusion criteria and outline of rationale and assumptions
  • Clinical and Commercial Analyzer: Each asset is scored on a set of characteristics that will determine their post-launch success, including clinical features such as efficacy, safety, and dosing regimen and commercial attributes such as price, company reputation, and marketing and sales force strength
  • Competitive Assessment: Visual representation of the results of the analyzer, depicting how the leading candidates compete
  • Product Dashboard: Compilation of all key product features, plus a proprietary SWOT analysis of each product
  • Clinical Data Summary: Listing of published clinical data for all products included in the analysis
Reasons to Buy

With the constantly evolving COVID-19 outbreak, players need rapidly updated and detailed information on the potential for success for emerging vaccines and therapies. GlobalData’s COVID-19 Clinical and Commercial Analyzer will allow clients to -
  • View scoring of assets which will impact their success in this dynamic field, with characteristics scored including clinical features such as safety and efficacy, and commercial features such as price and company reputation and marketing capabilities.
  • Two important features of this are that the scores are easily visualized in a chart clearly depicting where different assets stand in the field. Further, the scoring sheet is live, meaning that clients can change scoring parameters based on their individual needs and preferences.
  • Access to dashboards detailing out basic information for these agents such as mechanism of action, as well as GlobalData’s take on these assets, including SWOT analyses, with further linkage to summaries of available published clinical data for assets.
Please note this is delivered as an Excil file.

Table of Contents

Please Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us